Ali Asif 4

What Happened

• Ali Asif, Chief Financial Officer of Protagonist Therapeutics (PTGX), sold 8,588 shares on 2026-01-20 at $82.48 per share, generating proceeds of $708,338. The transaction was reported as an open-market/private sale and was disclosed on a Form 4 filed 2026-01-21. This was a sale (routine liquidity event), not a purchase.

Key Details

• Transaction date and price: 2026-01-20 at $82.48 per share
• Shares sold: 8,588; Gross proceeds: $708,338
• Shares owned after transaction: not specified in the summary provided (see Form 4 for post-transaction holdings)
• Footnote: Sale executed to cover tax withholding obligations upon settlement of restricted stock units
• Filing timeliness: Form 4 was filed the next day (2026-01-21), which is within typical Section 16 reporting timelines

Context

• The sale was reported as a tax-withholding disposition tied to RSU settlement. Sales to cover taxes are common and generally considered routine liquidity rather than a direct signal about an insider’s view of the company’s prospects. Purchases (when they occur) typically carry more weight for interpreting insider sentiment.